Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors.

Catherine Chanfreau,Kristine E. Lynch,Jiwon Chang,Daniel Jacob Becker,Daphne R. Friedman,Donna Rivera,Scott L. DuVall,Julie Ann Lynch

Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors.

2018

Catherine Chanfreau
Kristine E. Lynch
Jiwon Chang
Daniel Jacob Becker
Daphne R. Friedman
Donna Rivera
Scott L. DuVall
Julie Ann Lynch

e18832Background: Oral tyrosine kinase inhibitors (TKIs) have substantially improved treatment and outcomes of chronic myeloid leukemia (CML) since Imatinib approval in 2001. Treatment options for ...

Keywords:

Myeloid leukemia
Tyrosine kinase
Pathology
Cancer research
Medicine
Imatinib
treatment options

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations